0001209191-23-027205.txt : 20230503
0001209191-23-027205.hdr.sgml : 20230503
20230503211511
ACCESSION NUMBER: 0001209191-23-027205
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schneyer Mark C.
CENTRAL INDEX KEY: 0001899977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 23886080
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-01
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001899977
Schneyer Mark C.
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
EVP, Chief Financial Officer
0
Stock Options (Right to Buy)
21.75
2023-05-01
4
A
0
89936
0.00
A
2033-05-01
Common Stock
89936
89936
D
Restricted Stock Units
2023-05-01
4
A
0
27259
0.00
A
Common Stock
27259
27259
D
25% of the shares subject to the Stock Option will vest and become exercisable on May 1, 2024. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The restricted stock units vest in four equal annual installments beginning May 1, 2024.
/s/ Austin D. Kim, Attorney-in-Fact
2023-05-03